Antibiotic Trials For COPD May Hinge On Patient-Reported Outcomes, FDA Says
Executive Summary
Outcomes that are clinically important to patients should be the focus of clinical trials for antibiotics to treat acute bacterial exacerbation of chronic bronchitis in patients with chronic obstructive pulmonary disease, FDA recommends in a 1draft guidance released Aug. 21You may also be interested in...
Industry Collaboration Targets Patient-Reported Outcomes Tools In Cancer
Antimicrobial Placebo-Control Trial Should Be Required By FDA – PhRMA
Rx Misbranding Penalties Should Be Stronger To Stop Counterfeiting, FDA Says
Industry also seems supportive of the idea, while Pew touts the power of the power of track-and-trace as a deterrent.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: